Pharmaceuticals

  1. 20 Nov 2017  |  North America

    Global Biologics Market—Companies-to-Action

    Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

    This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

    $3,000.00
  2. 27 Sep 2017  |  Africa

    East African Pharmaceutical Market, Forecast to 2021

    Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

    Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...

    $4,950.00
  3. 19 Apr 2017  |  Asia Pacific

    Global CRO Market, Forecast to 2021

    The Global CRO Market to Reach $64.58 Billion by 2021

    The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...

    $4,950.00
  4. 02 Mar 2017  |  Global

    Biomarkers Enabling Diabetes and Obesity Management

    Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management

    Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...

    $4,950.00